Atlas Trials

Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)

Clinical trial NCT06402851 · RECRUITING

Trial details

NCT number
NCT06402851
Sponsor
Hospital Sirio-Libanes
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Atrium; FibrillationChronic Kidney Diseases
Start date
2024-12-18
Primary completion
2026-12-01
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.